Oncotelic updates Q1 2025 financial results and business outlook
Oncotelic Therapeutics reported updated financial results for the first quarter of 2025 and adjusted its business outlook for the remainder of the year to reflect current operational status and market dynamics.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed